Hims & Hers Takes On Novo: What We Know Right Now! скачать в хорошем качестве

Hims & Hers Takes On Novo: What We Know Right Now!

Hims & Hers introduced an oral GLP-1 today and the market cheered the news before selling the stock off. Here's what we know so far and why this may not be the risk some investors thought it was. Asymmetric Investing is built on proven frameworks and consistent analysis, which you can find here: 💰START HERE with a Free Asymmetric Investing Subscription: https://asymmetric-investing.beehiiv.... 📈INVESTORS Can See the Market-Beating Performance of The Asymmetric Portfolio: https://asymmetric-investing.beehiiv.... 🚀Invest on AutoPilot (home of the Pelosi Tracker): https://marketplace.joinautopilot.com... 📈Fiscal AI is the best tool in finance. Try it now: ​​https://fiscal.ai/asym A portion of this video is sponsored by The Motley Fool. Visit https://fool.com/asym to get access to my special offer. The Motley Fool Stock Advisor returns are 983% as of 12/30/2025 and measured against the S&P 500 returns of 195% as of 12/30/2025. Past performance is not an indicator of future results. All investing involves a risk of loss. Individual investment results may vary, not all Motley Fool Stock Advisor picks have performed as well. 00:00 Stock Surge 00:35 Details of the New Product 02:42 Legal and Technological Challenges 06:24 Market Reactions and Future Outlook 07:41 Conclusion and Final Thoughts